[Neurotoxin candidates as pathogenic agents of Parkinson's disease].
Naoi
M
M
Department of Biosciences, Nagoya Institute of Technology, Japan.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000032:analysis* / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000473:pathology; D001923:Brain Chemistry; D004195:Disease Models, Animal; D006801:Humans; D007546:Isoquinolines / Q000134:cerebrospinal fluid / Q000378:metabolism; D009498:Neurotoxins / Q000032:analysis* / Q000378:metabolism; D010300:Parkinson Disease / Q000209:etiology / Q000378:metabolism*; D051381:Rats
D007546:Isoquinolines; D009498:Neurotoxins; C036617:salsolinol; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine